Cart summary

You have no items in your shopping cart.

GS967

SKU: orb1306639

Description

GS967 is a selective small molecule inhibitor of the cardiac late sodium current (late INa). It is a valuable research tool for investigating cardiac arrhythmias, ischemia-reperfusion injury, and heart failure in both in vitro and in vivo experimental models.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number1262618-39-2
MW347.22
Purity>99.99% (May vary between batches)
FormulaC14H7F6N3O
SMILESFC(F)(F)Oc1ccc(cc1)-c1ccc2nnc(n2c1)C(F)(F)F
TargetSodium Channel
SolubilityDMSO:50 mg/mL (144 mM);10% DMSO+90% Corn Oil:2.5 mg/mL (7.2 mM)

Bioactivity

Target IC50
Late INa:0.13 μM
In Vivo
GS967 effectively mitigates and reverses the proarrhythmic consequences induced by the late INa enhancer ATX-II, the IKr inhibitor E-4031, as well as methoxamine, 1 clofilium, and ischemia-induced arrhythmias. It significantly reduces the proarrhythmic effects of these agents and suppresses ischemia-induced arrhythmias. Additionally, GS967 decreases INaP in a frequency-dependent manner, showcasing a use-dependent block (UDB) that is more potent than that of ranolazine and lidocaine, with an IC50 of 0.07 μM compared to 16 μM and 17 μM respectively. This compound also maintains its effectiveness against a common long QT syndrome mutation (delKPQ) and prevents ischemia-induced alternans in both the left atrium and ventricle, alongside reducing depolarization and repolarization heterogeneity induced by ischemia. Notably, GS967 does not affect heart rate, arterial blood pressure, PR and QT intervals, or QRS duration, although it slightly reduces contractility during ischemia, aligning with late INa inhibition effects.
In Vitro
GS967 at concentrations of 10, 100, and 300 nM fully counteracts ATX-II's (10 nM) ability to prolong and vary the action potential duration (APD) in ventricular myocytes. It demonstrates an approximate IC50 value of ~10 nM and reduces the beat-to-beat variability of APD.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Na+ channels, Na channels, inhibit, late INa ,isolated hearts, late INa ,ventricular myocytes, Inhibitor, GS 967, GS 458967, GS967, GS-967, GS458967, GS-458967, Sodium Channel, SodiumChannel

Similar Products

  • GS967 [orb1226647]

    >98%(HPLC)

    1262618-39-2

    347.2

    C14H7F6N3O

    1 g, 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

GS967 (orb1306639)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 70.00
5 mg
$ 90.00
1 ml x 10 mM (in DMSO)
$ 100.00
10 mg
$ 120.00
25 mg
$ 210.00
50 mg
$ 340.00
100 mg
$ 570.00
200 mg
$ 800.00
500 mg
$ 1,210.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry